Fischer Medical Ventures Appoints Tay Chin Kwang as Finance Director
Fischer Medical Ventures has appointed Tay Chin Kwang as Group Director of Finance, Chairman Office, to strengthen leadership and drive global healthcare and life sciences growth.
Fischer Medical Ventures | 22/07/2026 | By News Bureau
The initiative aims to equip pharmaceutical companies, biotech firms and research institutions with AI-driven molecular analysis tools to accelerate drug discovery and advance computational biology research.
Fischer Medical Ventures | 17/07/2026 | By News Bureau
Fischer Medical Ventures Strengthens AI Life Sciences Partnership with Nanyang Biologics
Fischer Medical Ventures and Nanyang Biologics are expanding their strategic collaboration to advance Artificial Intelligence (AI)-powered life sciences research and biotechnology innovation in India.
Fischer Medical Ventures | 14/07/2026 | By News Bureau | 103
Fischer Medical Ventures (FMV), through its wholly owned subsidiary Time Medical International Ventures India, has entered into a strategic partnership with Indonesia, in collaboration with PT Pharmindo Rimpang Kokoh (PT Pariko), to support the country’s tuberculosis eradication efforts with advanced portable, AI-enabled X-ray systems.
Fischer Medical Ventures | 01/12/2025 | By Dineshwori | 280
Fischer Medical Ventures Subsidiary Powers Philippines' First Locally-Funded MRI Facility in Bulacan
The Province of Bulacan has inaugurated the Philippines’ first locally funded Magnetic Resonance Imaging (MRI) facility—developed by Time Medical International Ventures (India), a wholly owned subsidiary of Fischer Medical Ventures.
Fischer Medical Ventures | 24/11/2025 | By Dineshwori | 324
Time Medical Launches VEGA, a New Low-Field TOF MRI for Aneurysm Screening
Time Medical International Ventures, a wholly owned subsidiary of Fischer Medical Ventures, has unveiled VEGA, a heavily optimised permanent-magnet MRI system engineered specifically for rapid, non-contrast TOF angiographic screening of unruptured intracranial aneurysms.
Fischer Medical Ventures | 17/11/2025 | By Dineshwori | 491
Fischer Medical Ventures Appoints Dr. Iype Cherian as Director
Fischer Medical Ventures has appointed globally renowned neurosurgeon and innovator Dr. Iype Cherian as Director, strengthening its leadership as the company advances its next-generation intraoperative MRI technology - DRIS–iMRI Medharanya.
Fischer Medical Ventures | 14/11/2025 | By Dineshwori | 502
Nanyang Biologics, NVIDIA, HPE and Equinix Collaborate to Build AI Drug Discovery Platform
Fischer Medical Ventures’ associate company, Nanyang Biologics (NYB), has entered into a strategic collaboration with global technology leaders NVIDIA, Hewlett Packard Enterprise (HPE), and Equinix to build VECURA – an AI-powered drug discovery platform.
Fischer Medical Ventures | 03/09/2025 | By Dineshwori | 431
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy